ai-CANCERCH
Commercial- Indications
- Lung cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Esophageal cancer, Ovarian cancer
Company intelligence / Profile preview
GC Genome is a leading South Korean clinical genomics and diagnostics company offering CAP-accredited laboratory services. It specializes in next-generation sequencing-based tests for oncology, rare diseases, prenatal/neonatal screening, and health check-ups. The company has launched several proprietary products including AI-driven multi-cancer early detection tests ("AI-CANCERCH"), personalized health management panels ("GeneSketch"), miscarriage analysis panels ("M-screen"), and microbiome testing. Recent research has been presented at major international conferences such as ASCO, AACR, ESMO; peer-reviewed results include publications in Nature Communications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GC Genome.